Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition - Top-Institutions - MDSpire

Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition

  • By

  • Faria Athar

  • Sarah Gregory

  • Emma J Houston

  • Nicole M Templeman

  • January 3, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    University of Pittsburgh
    University of Pittsburgh

    Pittsburgh, PA

    Key Differentiators

    • Endocrinology
    • Women's Health
    • Epidemiology

  • #2

    Johns Hopkins University
    Johns Hopkins University

    Baltimore, MD

    Key Differentiators

    • Endocrinology
    • Obstetrics and Gynecology
    • Women's Health Research

  • #3

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Endocrinology
    • Gynecology
    • Metabolic Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Endocrinology
    • Women's Health
    • Metabolic Disorders

  • #5

    Northwestern University
    Northwestern University

    Chicago, IL

    Key Differentiators

    • Obstetrics and Gynecology
    • Endocrinology
    • Women's Health Research

Original Source(s)

Insulin Levels Early in Perimenopause Inform Vasomotor Symptom Incidence Across the Menopausal Transition

  • by Faria Athar, Sarah Gregory, Emma J Houston, Nicole M Templeman

  • January 3, 2026

Related Content

Physicians Exiting Practice Earlier

Researchers identify burnout-associated workplace pressures and caregiving responsibilities as major contributors to physician attrition.

Integrative approaches to healthy aging in postmenopausal women: the synergistic benefits of exercise combined with functional foods and dietary supplements

HRT, Menopause, and the Brain: New Data

A large UK Biobank analysis examines how menopause and hormone therapy relate to mental health, cognition, and brain structure in midlife women.